Fibroblast extracellular matrix gene expression in response to keratinocyte-releasable stratifin

Journal of Cellular Biochemistry

Volumn 98, Issue 2, 2006, Pages 383-393

  Ghaffari, Abdi ^a   Li, Yunyaun ^b   Karami, Ali ^b   Ghaffari, Mazyar ^b   Tredgel, Edward E ^b   Ghahary, Aziz ^a,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c 344A JBRC ^*  (Canada)

Author keywords

14 3 3 ; Cell cell interaction; Fibroblast; Keratinocyte; MMP; Stratifin

Indexed keywords

COLLAGEN TYPE 1; FIBRONECTIN; MATRIX METALLOPROTEINASE; PROTEIN 14 3 3; STRATIFIN; UNCLASSIFIED DRUG;

ARTICLE; CELL INTERACTION; CONCENTRATION RESPONSE; DOSE RESPONSE; EPITHELIZATION; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION PROFILING; GENETIC SELECTION; HUMAN; HUMAN CELL; HYDROLYSIS; KERATINOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN FIBROBLAST; TARGET CELL; WESTERN BLOTTING; WOUND HEALING;

CELLS, CULTURED; COCULTURE TECHNIQUES; COLLAGEN TYPE I; COLLAGENASES; CULTURE MEDIA, CONDITIONED; DERMIS; EXONUCLEASES; EXTRACELLULAR MATRIX; FIBROBLASTS; GENE EXPRESSION; HUMANS; KERATINOCYTES; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASES; NEOPLASM PROTEINS; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASES; TUMOR MARKERS, BIOLOGICAL; WOUND HEALING;

EID: 33646132041     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20782     Document Type: Article

References (37)

1. Abe M, Kawamoto K, Okamoto H, Horiuchi N. 2001. Induction of collagenase-2 (matrix metalloproteinase-8) gene expression by interleukin-1beta in human gingival fibroblasts. J Periodontal Res 36:153-159.
2. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, De Carlo A, Engler JA. 1993. Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 4:197-250.
3. Deitch EA, Wheelahan TM, Rose MP, Clothier J, Cotter J. 1983. Hypertrophic burn scars: Analysis of variables. J Trauma 23:895-898.
4. Dong Z, Katar M, Alousi S, Berk RS. 2001. Expression of membrane-type matrix metalloproteinases 4, 5, and 6 in mouse corneas infected with P. aeruginosa. Invest Ophthalmol Vis Sci 42:3223-3227.
5. Folgueras AR, Pendas AM, Sanchez LM, Lopez-Otin C. 2004. Matrix metalloproteinases in cancer: From new functions to improved inhibition strategies. Int J Dev Biol 48:411-424.
6. Gaire M, Magbanua Z, McDonnell S, McNeil L, Lovett DH, Matrisian LM. 1994. Structure and expression of the human gene for the matrix metalloproteinase matrilysin. J Biol Chem 269:2032-2040.
7. Ghahary A, Shen YJ, Nedelec B, Wang R, Scott PG, Tredget EE. 1996. Collagenase production is lower in post-burn hypertrophic scar fibroblasts than in normal fibroblasts and is reduced by insulin-like growth factor-1. J Invest Dermatol 106:476-481.
8. Ghahary A, Tredget EE, Chang LJ, Scott PG, Shen Q. 1998. Genetically modified dermal keratinocytes express high levels of transforming growth factor-beta1. J Invest Dermatol 110:800-805.
9. Ghahary A, Karimi-Busheri F, Marcoux Y, Li Y, Tredget EE, Taghi KR, Li L, Zheng J, Karami A, Keller BO, Weinfeld M. 2004. Keratinocyte-releasable stratifin functions as a potent collagenase-stimulating factor in fibroblasts. J Invest Dermatol 122:1188-1197.
10. Ghahary A, Marcoux Y, Karimi-Busheri F, Li Y, Tredget EE, Kilani RT, Lam E, Weinfeld M. 2005. Differentiated keratinocyte-releasable stratifin (14-3-3 sigma) stimulates MMP-1 expression in dermal fibroblasts. J Invest Dermatol 124:170-177.
11. Johnson-Wint B. 1980. Regulation of stromal cell collagenase production in adult rabbit cornea: In vitro stimulation and inhibition by epithelial cell products. Proc Natl Acad Sci USA 77:5331-5335.
12. Kahari VM, Saarialho-Kere U. 1997. Matrix metalloproteinases in skin. Exp Dermatol 6:199-213.
13. Karimi-Busheri F, Marcoux Y, Tredget EE, Li L, Zheng J, Ghoreishi M, Weinfeld M, Ghahary A. 2002. Expression of a releasable form of annexin II by human keratinocytes. J Cell Biochem 86:737-747.
14. Katz AB, Taichman LB. 1999. A partial catalog of proteins secreted by epidermal keratinocytes in culture. J Invest Dermatol 112:818-821.
15. Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G. 1996. Biochemical characterization of human collagenase-3. J Biol Chem 271:1544-1550.
16. Lam E, Kilani RT, Li Y, Tredget EE, Ghahary A. 2005. Stratifin-induced matrix metalloproteinase-1 in fibroblast is mediated by c-fos and p38 mitogen-activated protein kinase activation. J Invest Dermatol 125:230-238.
17. Maas-Szabowski N, Stark HJ, Fusenig NE. 2000. Keratinocyte growth regulation in defined organotypic cultures through IL-1-induced keratinocyte growth factor expression in resting fibroblasts. J Invest Dermatol 114:1075-1084.
18. Mackay AK, Ballin M, Pelina MD, Farina AK, Nason AM, Hartzler JL, Thorgeirsson UP. 1992. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumour and normal cell lines. Invasion Metastasis 12:168-184.
19. Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, Geoghegan KF, Hambor JE. 1996. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 97:761-768.
20. Moon SE, Dame MK, Remick DR, Elder JT, Varani J. 2001. Induction of matrix metalloproteinase-1 (MMP-1) during epidermal invasion of the stroma in human skin organ culture: Keratinocyte stimulation of fibroblast MMP-1 production. Br J Cancer 85:1600-1605.
21. Moon SE, Bhagavathula N, Varani J. 2002. Keratinocyte stimulation of matrix metalloproteinase-1 production and proliferation in fibroblasts: Regulation through mitogen-activated protein kinase signalling events. Br J Cancer 87:457-464.
22. Mott JD, Werb Z. 2004. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 16:558-564.
23. Murphy G, Knauper V, Atkinson S, Butler G, English W, Hutton M, Stracke J, Clark I. 2002. Matrix metalloproteinases in arthritic disease. Arthritis Res 4 Suppl 3:539-549.
24. Nagase H, Woessner JF Jr. 1999. Matrix metalloproteinases. J Biol Chem 274:21491-21494.
25. Niessen FB, Spauwen PH, Schalkwijk J, Kon M. 1999. On the nature of hypertrophic scars and keloids: A review. Plast Reconstr Surg 104:1435-1458.
26. Niessen FB, Andriessen MP, Schalkwijk J, Visser L, Timens W. 2001. Keratinocyte-derived growth factors play a role in the formation of hypertrophic scars. J Pathol 194:207-216.
27. Pendas AM, Knauper V, Puente XS, Llano E, Mattei MG, Apte S, Murphy G, Lopez-Otin C. 1997. Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution. J Biol Chem 272:4281-4286.
28. Pozuelo RM, Geraghty KM, Wong BH, Wood NT, Campbell DG, Morrice N, Mackintosh C. 2004. 14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking. Biochem J 379:395-408.
29. Rheinwald JG, Green H. 1975. Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizing colonies from single cells. Cell 6:331-343.
30. Satoh J, Kurohara K, Yukitake M, Kuroda Y. 1999. The 14-3-3 protein detectable in the cerebrospinal fluid of patients with prion-unrelated neurological diseases is expressed constitutively in neurons and glial cells in culture. Eur Neurol 41:216-225.
31. Saus J, Quinones S, Otani Y, Nagase H, Harris ED Jr, Kurkinen M. 1988. The complete primary structure of human matrix metalloproteinase-3. Identity with stromelysin. J Biol Chem 263:6742-6745.
32. Schenk S, Quaranta V. 2003. Tales from the crypt[ic] sites of the extracellular matrix. Trends Cell Biol 13:366-375.
33. Scott PG, Ghahary A, Tredget EE. 2000. Molecular and cellular aspects of fibrosis following thermal injury. Hand Clin 16:271-287.
34. Stoll S, Garner W, Elder J. 1997. Heparin-binding ligands mediate autocrine epidermal growth factor receptor activation in skin organ culture. J Clin Invest 100:1271-1281.
35. Swann DA, Garg HG, Jung W, Hermann H. 1985. Studies on human scar tissue proteoglycans. J Invest Dermatol 84:527-531.
36. Thery C, Boussac M, Veron P, Ricciardi-Castagnoli P, Raposo G, Garin J, Amigorena S. 2001. Proteomic analysis of dendritic cell-derived exosomes: A secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 166:7309-7318.
37. Wang X, Yi J, Lei J, Pei D. 1999. Expression, purification and characterization of recombinant mouse MT5-MMP protein products. FEBS Lett 462:261-266.